In order to reveal the lipidomic changes induced by PLA2G7 impairment, cellular lipidomic profiles were analyzed in ERG positive VCaP prostate cancer cells expressing PLA2G7 at high levels (Figure 2A). The gene discussed is PLA2G7; the disease is prostate carcinoma.